You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

taxonomy for: BIO IPCC Conference

Speaking Opportunities at BIO

Submitted by admin on Fri, 2013-08-09 14:25

Indian Supreme Court Ruling Negatively Affects Innovation

Submitted by ggoodno on Mon, 2013-04-08 10:57

Participating Companies

As of 2/4/16
 
Alkermes, Inc.
Alnylam Pharmaceuticals
ARIAD Pharmaceuticals, Inc.
Bavarian Nordic
Baxalta Incorporated
Blueprint Medicines
Brinks Gilson & Lione
Eli Lilly
Elmore Patent Law Group, PC
FB Rice
Fenwick & West LLP
Fitzpatrick, Cella, Harper & Scinto
Foley Hoag LLP
Forresters
Freehills Patent Arrtoneys
ImmunoGen, Inc.
Ionis Pharmaceuticals, Inc.
Johnson & Johnson
Juno Therapeutics, Inc.
Kaye Scholer, LLP
Kirkland & Ellis LLP
Lee & Ko
McDonnell Boehnen Hulbert & Berghoff LLP
Milgrim IP
Momenta Pharmaceuticals, Inc
Monsanto Company
Nutter
Nutter, McClennen & Fish, LLP
Potter Clarkson LLP
Seed Intellectual Property Law Group PLLC
Seed IP Law Group
Sterne, Kessler, Goldstein & Fox PLLC
WilmerHale
Wragge Lawrence Graham & Co, LLP
Zymeworks, Inc.
 
 
 
 
 
 
 
 
 
 

 

Conferences and Events: 
BIO IP Counsels Committee Conference

CLE Credit

BIO will be offering continuing legal education credit at the 2016 IPCC Conference. Application for CLE credit will be submitted in California and Virginia, and attorneys will be notified if BIO receives credit approval.. Our IPCC sessions do not meet Texas' CLE eligibility criteria, as it is considered a business meeting, and as such we will not be submitting applications to the Texas State Bar. Attorneys needing CLE credit from Texas and other states are welcome to sign in, pick up the CLE forms and apply to their jurisdictions on their own. BIO will provide you with all the materials and documentation required to apply with your individual state CLE Boards.

Conferences and Events: 
BIO IP Counsels Committee Conference

Intellectual Property Counsels Committee

Submitted by admin on Fri, 2011-07-29 16:43

Intellectual Property Counsels’ Committee

Submitted by admin on Fri, 2011-07-29 16:16

Past & Future Conferences

Future Conferences:
2016 BIO IPCC Spring Conference & Meeting
San Antonio, TX
March 30 - April 1, 2016
 
2016 BIO IPCC Fall Conference & Meeting
Savannah, GA
November
 
Past Conferences
2015 BIO IPCC Fall Conference & Meeting
Cary/Raleigh, NC
November 16-18
Click here to view a copy of the agenda.
 
2015 BIO IPCC Spring Conference & Meeting
St. Louis, MO
April 15-17
Click here to view a copy of the agenda.
 
2014 BIO IPCC Fall Conference & Meeting
Nashville, TN
November 10-12
Click here to view a copy of the agenda.
 
2014 BIO IPCC Spring Conference & Meeting
Palm Springs, CA
April 23-25
Click here to view a copy of the agenda.
 
2013 BIO IPCC Fall Conference & Meeting
Washington, DC
November 6-8
Click here to view a copy of the agenda.
 
2013 BIO IPCC Spring Conference & Meeting
San Diego, CA
March 25-27
Click here to view a copy of the agenda.
 
2012 BIO IPCC Fall Conference & Meeting
Charleston, SC
November 12-14
Click here to view a copy of the agenda
 
2012 BIO IPCC Spring Conference & Meeting
Austin, TX
April 16-18
Click here to view a copy of the agenda 
 
2011 BIO IPCC Fall Conference & Meeting
New York, NY
November 2-4
Click here to view a copy of the agenda 
 
2011 BIO IPCC Spring Conference & Meeting
Seattle, WA
April 13-15
Click here to view a copy of the draft agenda
 
2010 BIO IPCC Fall Conference & Meeting
Boston, MA
October 18-20
Click here to view a copy of the draft agenda
 
2010 BIO IPCC Spring Conference & Committee Meeting
New Orleans, LA
April 19-21
Click here to view a copy of the draft agenda
 
2009 BIO IPCC Fall Conference & Committee Meeting
Washington, DC
October 26-28
Click here to view a copy of the draft agenda
 
2009 BIO IPCC Spring Conference & Committee Meeting
Phoenix, AZ
March 25-27
Click here to view a copy of the draft agenda
 
2008 BIO IPCC Fall Conference & Committee Meeting
Orlando, FL
October 20-22
Click here to view a copy of the draft agenda
Conferences and Events: 
BIO IP Counsels Committee Conference

Sponsors

Conferences and Events: 
BIO IP Counsels Committee Conference

Agenda

2015 BIO IPCC-FALL CONFERENCE PROGRAM AGENDA
(subject to change)
 

Monday, November 16, 2015

Registration                                                                                                             
11:30 am – 3:30 pm
The Umstead Hotel & Spa, 100 Woodland Pond Dr, Cary, NC  27513
 
Please pick up your conference badge and materials in The Hotel.  If you are unable to pick up your materials during this time, registration will reopen on Tuesday, November 17th at 7:30 am.
 
 
IP Counsels Committee Business Meeting & Working Luncheon                                           
12:00 pm – 3:15 pm
Open to IP Counsels Committee company members and their representatives only.
Copies of the Committee Business Meeting Agenda will be provided onsite.
 
 
Refreshment Break
3:15 pm - 3:30 pm
Sponsored by: Marshall, Gerstein & Borun LLP
 
 
Pre-Conference Workshop: The Evolving Landscape of Biosimilars Litigation in the United States
3:30 pm – 4:30 pm
Sponsored by: O'Melveny & Myers, LLP

This panel will offer an in-depth analysis of the Amgen v. Sandoz case.  Topics to be addressed include: the Sandoz application and subsequent litigation; prospects for en banc and Supreme Court review; consequences of the Federal Circuit decision; and a look at what is next in the pipeline.
 
Speakers:
  Lisa Barons Pensabene, Partner & Head of Life Sciences Litigation, O'Melveny & Myers, LLP
  Filko Prugo, Partner, O'Melveny & Myers, LLP
  Timothy Creagan, Chief Patent Counsel, Genzyme, A Sanofi Company
  Immac Thampoe, Managing IP Counsel, Biologics & Vaccines,  Merck & Co.
  Brian Barrett, Senior Director & Assistant General Patent Counsel, Eli Lilly & Company
 
 
Welcome Reception at ORO Restaurant & Lounge
5:00 pm – 7:30 pm
18 E Martin Street, Raleigh, NC
Prior RSVP is required.
Sponsored by: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
Please meet in the hotel's front lobby at 5:00 pm sharp to catch a bus to the ORO Restaurant & Lounge in downtown Raleigh.
 
   

Tuesday, November 17, 2015

Chairman’s Welcome & Breakfast: Industry-University Transactions - Shrinking the Timeline
7:30 am – 8:30 am
The Umstead Hotel & Spa - The Umstead Ballroom
Sponsored by: Brinks Gilson & Lione
 
Get your next university deal done faster.  Panelists will discuss top of mind issues in negotiating university biotechnology licenses and creative solutions.
 
Moderator: Allen Baum, Shareholder, Brinks Gilson & Lione
 
Panelists:
  Kelly Sexton, PhD, Director, Office of Technology Transfer, North Carolina State University
  Kimberly Parker, Global Head Legal Transactions, Novartis
  Barry Myers, MD, PhD, Interim Director, Duke University Office of Licensing and Ventures
  Jackie Quay, Interim Director, University of North Carolina, Office of Technology Development
 
 
Session 1: Antibody Drug Protection -  Tale of Two Systems
8:45 am – 10:00 am
The Umstead Hotel & Spa - The Umstead Ballroom
Sponsored by: Choate Hall & Stewart LLP
 
More and more biotech companies are developing antibody drugs for various diseases.  But protecting antibody drugs faces significant challenges both in the US and Europe.  Specifically, the panel will discuss the written description challenge for broad antibody protection in the US and inventive step challenge for specific antibody protection in the Europe and explore options that biotech companies have.
 
Moderator: Fangli Chen, PhD, Partner, Choate Hall & Stewart LLP
 
Panelists:
  Hugh Goodfellow, Partner, Carpmaels & Ransford
  Brian Barrett, Senior Director & Assistant General Patent Counsel, Eli Lilly & Company
  Ken Dow, Vice President, Patents & Assistant Patent Counsel, Johnson & Johnson
 
 
Refreshment Break
10:00 am - 10:15 am
Sponsored by: Marshall, Gerstein & Borun LLP
 
 
Session 2: The Supreme Court Speaks... Again
10:15 am - 11:45 am
The Umstead Hotel & Spa - The Umstead Ballroom
Sponsored by: Choate Hall & Stewart LLP
 
From claim construction to Spider Man, this panel will discuss several recent Supreme Court decisions impacting the biotechnology IP community and the expected fall out from those decisions moving forward.  Issues discussed include ongoing fall out from the Court’s recent Section 101 decisions; the evolving inducement standard in light of Commil; the state of the patent misuse doctrine in view of Kimble v Marvel; and claim construction after Teva v Sandoz.
 
Moderator: Eric Marandett, Partner, Choate Hall & Stewart LLP
 
Panelists:
  Daniel Winston, Partner, Choate Hall & Stewart LLP
  Chris Chung, Chief IP Counsel, Sanofi Pasteur
  James Harrington, Senior Vice President, Chief IP Counsel, Shire Pharmaceuticals

 
Luncheon Keynote
12:00 pm – 1:15 pm
The Umstead Hotel & Spa - The Umstead Ballroom
Sponsored by: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
 
Session 3: Patentable Subject Matter - Where Are We Now?
1:30 pm – 2:45 pm
The Umstead Hotel & Spa - The Umstead Ballroom
Sponsored by: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
Mayo, Myriad, Sequenom—it seems as if every day another shoe drops on the ability to patent biotechnology. This session will explore the topic in depth and discuss the legal and policy implications of the current case law, including the perspective of a current judge on the Patent Trial and Appeal Board.
 
Moderator:  Jennifer Swan, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
Panelists:
  Howard Levine, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  Jacqueline D. Wright Bonilla, Administrative Patent Judge, Patent Trial and Appeal Board, U.S. Patent and Trademark Office
  Amanda Stark, Principal, Patent Attorney, Griffith Hack
  Virginia Campen,  Assistant General Counsel, Patents, GlaxoSmithKline
 
 
Refreshment Break
2:45 pm - 3:00 pm
Sponsored by: Marshall, Gerstein & Borun LLP
 

Session 4: The Evolution of Double Patenting
3:00 pm – 4:00 pm
The Umstead Hotel & Spa - The Umstead Ballroom
Sponsored by: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
Obviousness type double patenting was created to fill a gap in the patent statute, but it has moved beyond that narrow purpose and has worked havoc on otherwise valid and unobvious patents.  This panel will discuss the recent case law of the Federal Circuit, strategies to take during prosecution to reduce risk, and legislative efforts to address this problem.
 
Moderator:  Leslie McDonell, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
Panelists:
  Bob Armitage, former Sr. Vice President & General Counsel, Eli Lilly & Company
  Nathan Edwards, PhD, IP Counsel, Biogen
  Alissa Lipton, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 
 
 
Dinner Reception at the North Carolina Museum of Natural Sciences 
5:00 pm – 9:00 pm
102 N Salisbury St, Raleigh, NC
Prior RSVP required
 
Dinner sponsored by: McDonnell Boehnen Hulbert & Berghoff LLP
 
Meet in the Hotel's lobby at 5:15 pm sharp to catch a shuttle bus to the NC Museum of Natural Sciences. Please be sure to wear your name badge. Your pass to get onto the bus is located on the back of your badge. Enjoy a scavenger hunt, followed by cocktails & dinner.
 
 

Wednesday, November 18, 2015

Networking Breakfast
8:00 am – 9:15 am
The Umstead Hotel & Spa - The Umstead Ballroom
 
 
Session 5: Biosimilars: What We Can Expect from the European & South Korean Experience
9:30 am – 10:45 am
The Umstead Hotel & Spa - The Umstead Ballroom
Sponsored by: Fitzpatrick, Cella, Harper & Scinto
 
The panel will discuss foreign biosimilars patent issues and litigations to date; will consider how post-grant review proceedings have been used in the biologics context; and will compare and contrast with the U.S.; concluding with lessons learned.
 
Moderator:  Christopher Borello, Partner, Fitzpatrick, Cella, Harper & Scinto
 
Panelists:
  Robert Schwartz, PhD, Partner, Fitzpatrick, Cella, Harper & Scinto
  Dominic Adair, Partner, Bristows
  Kevin Kyumin Lee, Partner, Kim & Chang
 
 
Refreshment Break
10:45 am - 11:00 am
Sponsored by: Marshall, Gerstein & Borun LLP
 
 
Session 6: “Life, the Universe & Everything:” What We’ve Learned from IPRs in the Life Sciences
11:00 am – 12:15 pm
The Umstead Hotel & Spa - The Umstead Ballroom
Sponsored by: Fitzpatrick, Cella, Harper & Scinto
 
In light of the handful of IPR decisions that have now completed through appeal, this panel will cover, among other things: the interface between life science litigation and IPRs; properly preparing IPR petitions to maximize potential for institution; addressing petitions effectively; tips and tactics including use of evidence, experts; what to expect concerning discovery and how to handle confidential information; the impact of IPRs on IP Strategy in the life science field; and the recent wave of third party hedge fund IPRs, their impact and the attempted responses from Congress and the USPTO.
 
Panelists:
  Claire Vasios, Vice President, IP, Alkermes, Inc.   
  Daniel Flint, IP Consultant, Biotechnology Industry Organization
  Ha Kung Wong, Partner, Fitzpatrick, Cella, Harper & Scinto
  Christina Schwarz, Partner, Fitzpatrick, Cella, Harper & Scinto
 
 
12:15 pm: Adjournment

 

Conferences and Events: 
BIO IP Counsels Committee Conference

Why Attend?

The BIO IP Counsels Committee Conference is an excellent opportunity for IP professionals to discuss current and future issues in the biotech patent landscape. Our upcoming 2016BIO IPCC SpringConference in San Antonio, TX is the ideal setting for BIO members and other industry IP professionals to come together to hear, discuss and learn about current and projected topics related to biotech IP.
 
If you are concerned with the implications of an ever-changing patent system on the biotechnology industry, this meeting is not to be missed. We invite you to join us in an informal, fun and informative setting to meet fellow industry legal and IP professionals, to make new acquaintances, to reconnect with old friends, and to take home a wealth of information – and maybe some new ideas.
 
 

TESTIMONIALS

 
“I attend the BIO-IPCC meetings regularly, and consider them a necessity for keeping up with developments in biotechnology law.  Not only are sessions cutting-edge and highly informative, but the speakers themselves are always authoritative and often intimately involved in using and influencing the laws on which they present.  Beyond the formal presentations, the BIO-IPCC organizers ensure that all attendees and presenters have ample enjoyable opportunities to socialize, and speak further, with their colleagues about issues of mutual concern in biotechnology law and business.  There is no other venue that offers better insights into biotechnology law, or a better chance to stay current with those who work with or make that law, than BIO-IPCC meetings.  I look forward to every one.”
~Andrew Torrance, MIT
 
"IPCC’s semi-annual meetings are the best value for keeping current on legal issues because the presentations are always BIO-focused.   The member-only sessions of IPCC meetings provide a unique opportunity to bring your company’s view into the debate on pending issues and to influence BIO’s position on IP legislation and policy.  The IPCC wants to meet you and learn what intellectual property issues are important for the success of your business. So join us in San Diego, CA."
~ Tom Kelley, Monsanto
 
“I have been attending the BIO IPCC conference for the past 6 years and I find that it’s an invaluable way to keep up with this ever-evolving field.  The sessions are extremely relevant and are designed to provide in-depth analysis as well as encourage informal discussion of current IP topics.  The evening events are a wonderful opportunity to make connections with other members of the BIO IP community, and to reconnect with attendees who have become friends and colleagues over the years.  It’s the one conference I try not to miss.”
~ Claire Vasios, Alkermes
 
"I have regularly attended BIO IPCC meetings for years because the business and legal information we discuss is always timely and directly relevant to BioPharma patent practice. The meeting size is large enough to represent a broad range of views, but not so large that attendees are reluctant to actively participate and debate issues. There is a nice mix of new and familiar faces, and BIO’s staff always makes the event fun with new meeting locations and creative group activities."
~ Anonymous
 
"The BIO IPCC has been consistently the most relevant and productive industry IP meeting that I attend.The meeting is regularly attended by many of the leading in-house patent lawyers in biotechnology and Pharma.  The topics covered are always an interesting mix of new case law and important policy issues that in-house patent counsel need to consider in advising their companies."
~ Jason Ferrone, Isis Pharmaceuticals, Inc.

 

Conferences and Events: 
BIO IP Counsels Committee Conference